<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rpmj</journal-id><journal-title-group><journal-title xml:lang="ru">Research'n Practical Medicine Journal</journal-title><trans-title-group xml:lang="en"><trans-title>Research and Practical Medicine Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2410-1893</issn><publisher><publisher-name>"QUASAR", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17709/2409-2231-2017-4-2-2</article-id><article-id custom-type="elpub" pub-id-type="custom">rpmj-182</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Review</subject></subj-group></article-categories><title-group><article-title>ФИЛЛОИДНЫЕ ОПУХОЛИ МОЛОЧНЫХ ЖЕЛЕЗ. СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ</article-title><trans-title-group xml:lang="en"><trans-title>PHYLLOID TUMORS OF MAMMARY GLANDS. CURRENT STATE OF THE PROBLEM</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7141-2502</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зикиряходжаев</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Zikiryakhodzhaev</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зикиряходжаев Азиз Дильшодович, доктор медицинских наук, профессор кафедры онкологии и рентгенорадиологии РУДН, руководитель отделения онкологии и реконструктивно-пластической хирургии молочной железы и кожи МНИОИ им. П. А. Герцена</p></bio><bio xml:lang="en"><p>Aziz D. Zikiryakhodzhayev, PhD, MD, Professor of the Department of Oncology and Radiology, Peoples Friendship University of Russia, Head of the Department of Oncology and Reconstructive Surgery of the Mammary Gland and Skin, P. Hertsen Moscow Oncology Research Institute</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1742-3205</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Широких</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Shirokikh</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Широких Ирина Михайловна, аспирант кафедры онкологии и рентгенорадиологии Медицинского института </p><p>Для корреспонденции: Адрес: 117198, Москва, ул. Миклухо-Маклая, д. 8</p></bio><email xlink:type="simple">Shirokikh-irina1@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харченко</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kharchenko</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Харченко Наталья Владимировна, доктор медицинских наук, профессор, заведующая кафедрой онкологии и рентгенорадиологии</p></bio><bio xml:lang="en"><p>Natalia V. Kharchenko, MD, professor, head of the Department of Oncology and Radiology</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Запиров</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zapirov</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Запиров Гаджимурад Магомедович, кандидат медицинских наук, доцент кафедры онкологии и рентгенорадиологии</p></bio><bio xml:lang="en"><p>Gadzhimurad M. Zapirov, PhD, associate professor of the Department of Oncology and Radiology</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сарибекян</surname><given-names>Э. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Saribekyan</surname><given-names>E. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сарибекян Эрик Карлович, доктор медицинских наук, ведущий научный сотрудник отделения онкологии и реконструктивно-пластической хирургии молочной железы и кожи </p><p>125284, Москва, 2-й Боткинский проезд, 3</p></bio><bio xml:lang="en"><p>Erik K. Saribekyan, MD, leading researcher of the Department of Oncology and reconstructive surgery of breast and skin</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аблицова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ablitsova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аблицова Наталья Валерьевна, кандидат медицинских наук, научный сотрудник отделения онкологии и реконструктивно-пластической хирургии молочной железы и кожи</p></bio><bio xml:lang="en"><p>Natalia V. Ablitsova, PhD, researcher of the Department of Oncology and reconstructive surgery of breast and skin</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермаков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ermakov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ермаков Анатолий Викторович, кандидат медицинских наук, младший научный сотрудник отделения онкологии и реконструктивно-пластической хирургии молочной железы и кожи</p></bio><bio xml:lang="en"><p>Anatoliy V. Ermakov, PhD, junior researcher of the Department of Oncology and reconstructive surgery of breast and skin</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кунда</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kunda</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кунда Михаил Александрович, кандидат медицинских наук, доцент кафедры онкологии и рентгенорадиологии</p></bio><bio xml:lang="en"><p>Victoria S. Sidorenko, pathologist nstructive surgery of breast and skin</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8264-9871</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сидоренко</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sidorenko</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сидоренко Виктория Сергеевна, врач-патологоанатом</p></bio><bio xml:lang="en"><p>Hrant S. Gevorgyan, postgraduate student of the Department of Urology, Oncology and Radiology of FPC MD RUPF on the base of the Department of Oncourology</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Геворгян</surname><given-names>Г. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Gevorgyan</surname><given-names>H. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Геворгян Грант Суренович, аспирант кафедры урологии, онкологии и радиологии ФПК МР РУДН, на базе отделения онкоурологии</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский университет дружбы народов; &#13;
Московский научно-исследовательский онкологический институт имени П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский радиологический центр» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples Friendship University of Russia; &#13;
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российский университет дружбы народов</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples Friendship University of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Московский научно-исследовательский онкологический институт имени П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский радиологический центр» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>17</day><month>06</month><year>2017</year></pub-date><volume>4</volume><issue>2</issue><fpage>13</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зикиряходжаев А.Д., Широких И.М., Харченко Н.В., Запиров Г.М., Сарибекян Э.К., Аблицова Н.В., Ермаков А.В., Кунда М.А., Сидоренко В.С., Геворгян Г.С., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Зикиряходжаев А.Д., Широких И.М., Харченко Н.В., Запиров Г.М., Сарибекян Э.К., Аблицова Н.В., Ермаков А.В., Кунда М.А., Сидоренко В.С., Геворгян Г.С.</copyright-holder><copyright-holder xml:lang="en">Zikiryakhodzhaev A.D., Shirokikh I.M., Kharchenko N.V., Zapirov G.M., Saribekyan E.K., Ablitsova N.V., Ermakov A.V., Kunda M.A., Sidorenko V.S., Gevorgyan H.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpmj.ru/rpmj/article/view/182">https://www.rpmj.ru/rpmj/article/view/182</self-uri><abstract><p>Филлоидные (листовидные) опухоли молочных желез являются редким заболеванием и составляют 0,3–0,5% от всех опухолей молочной железы. В связи с редкой частотой встречаемости, а также незначительным количеством проведенных рандомизированных исследований, изучающих данную патологию, на сегодняшний день отсутствует стандартизированный подход к диагностике и лечению филлоидных опухолей. Появляющиеся в литературе сообщения об этих редких случаях носят, как правило, описательный характер, что лишь подчеркивает трудность дифференциальной диагностики, выработки правильной тактики лечения таких больных. В связи с редкостью весьма затруднительна правильная диагностика данной патологии, которая требует как высококвалифицированного врача-диагноста при первичном контакте с такой пациенткой, так и врача-патологоанатома, устанавливающего окончательный морфологический диагноз. Нередко листовидные опухоли ошибочно принимают за фиброаденомы молочных желез. Такие трудности в правильной диагностике в предоперационном периоде могут привести к ошибкам в планировании лечения. Также до конца не ясны рекомендации лечения пациентов с таким диагнозом, так как до сих пор не существует принятых стандартов лечения как в русских, так и в зарубежных рекомендациях. В связи с тем, что данная патология молочных желез является редкой, принципы лечения основаны на небольших ретроспективных исследованиях и клинических наблюдениях. В рамках этого обзора мы обсудим результаты крупных ретроспективных исследований, включая данные по эпидемиологии, этиологии, диагностический подход, стратегии и результаты лечения этой сложной группы патологии молочных желез.</p></abstract><trans-abstract xml:lang="en"><p>Phylloid (leaf-shaped) breast tumors are a rare disease and constitute 0.3–0.5% of all breast tumors. Due to the rare frequency of occurrence, as well as the small number of randomized studies that have been conducted on this pathology, there is currently no standardized approach to the diagnosis and treatment of phylloid tumors. The reports about these rare cases appearing in the literature are, as a rule, descriptive, which only emphasizes the difficulty of differential diagnosis, the development of the correct tactics for treating such patients. In connection with the rarity, it is very difficult to diagnose correctly this pathology, which requires a highly qualified doctor as a diagnostician in the initial contact with such a patient, and a pathologist doctor who establishes the final morphological diagnosis. Often, leaf-shaped tumors are mistaken for mammary fibroadenomas. Such difficulties in correct diagnosis in the preoperative period can lead to errors in the planning of treatment. Also, the recommendations for the treatment of patients with this diagnosis are not fully understood, since up to now there are no accepted treatment standards in both Russian and foreign recommendations. Due to the fact that this pathology of mammary glands is rare, the principles of treatment are based on small retrospective studies and clinical observations. In this review, we will discuss the results of major retrospective studies, including data on epidemiology, etiology, diagnostic approach, strategies and results of treatment of this complex group of breast pathologies.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>филлоидная опухоль</kwd><kwd>листовидная опухоль</kwd><kwd>молочная железа</kwd><kwd>фиброэпителиальные опухоли молочных желез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>phylloid tumor</kwd><kwd>leaf-shaped tumor</kwd><kwd>mammary gland</kwd><kwd>fibroepithelial tumors of the mammary glands</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Atalay C, Kinas V, Celebioglu S. Analysis of patients with phylloides tumor of the breast. Turkish J Surg. 2014; 30 (3): 129–132. DOI: 10.5152/UCD.2014.2719</mixed-citation><mixed-citation xml:lang="en">Atalay C, Kinas V, Celebioglu S. Analysis of patients with phylloides tumor of the breast. Turkish J Surg. 2014; 30 (3): 129–132. DOI: 10.5152/UCD.2014.2719</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Волченко А. А., Пак Д. Д., Усов Ф. Н., Фетисова Е. Ю., Ефанов В. В. Гигантская листовидная опухоль молочной железы. Онкохирургия. 2012; 4 (2): 77–80.</mixed-citation><mixed-citation xml:lang="en">Volchenko AA, Pak DD, Usov FN, Fetisova EJu, Efanov VV. Giant phyllodes tumor of breast. Oncosurgery. 2012; 4 (2): 77–80. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Müller J. Über den feineren Ban und die Formen der Krankaften Geschwulste. Berlin: G Reiner. 1838; 1: 54–57.</mixed-citation><mixed-citation xml:lang="en">Müller J. Über den feineren Ban und die Formen der Krankaften Geschwulste. Berlin: G Reiner. 1838; 1: 54–57.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization Histological typing of breast tumors. Tumori. 1982; 68: 181–198.</mixed-citation><mixed-citation xml:lang="en">World Health Organization Histological typing of breast tumors. Tumori. 1982; 68: 181–198.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Liang М, Ramaswamy В, Patterson С, McKelvey MT, Gordillo G, Nuovo GJ, et al. Giant breast tumors: Surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature. World J Surg Oncol. 2008; 6: 117. DOI: 10.1186/1477–7819–6-117</mixed-citation><mixed-citation xml:lang="en">Liang М, Ramaswamy В, Patterson С, McKelvey MT, Gordillo G, Nuovo GJ, et al. Giant breast tumors: Surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature. World J Surg Oncol. 2008; 6: 117. DOI: 10.1186/1477–7819–6-117</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tavassoli FA, Devilee P.Pathology and genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003. p. 99.</mixed-citation><mixed-citation xml:lang="en">Tavassoli FA, Devilee P.Pathology and genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003 .p. 99.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993; 71 (10): 3020–3024. DOI: 10.1002/1097–0142 (19930515)71:10&lt;3020:: AID-CNCR2820711022&gt;3.0.CO;2-G</mixed-citation><mixed-citation xml:lang="en">Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993; 71 (10): 3020–3024. DOI: 10.1002/1097–0142(19930515)71:10&lt;3020:: AID-CNCR2820711022&gt;3.0.CO;2-G</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, et al. Clinicopathologic features and long-term outcom es of 2 93phyllodes tum ors of the breast. Ann Surg Oncol 2007; 14 (10): 2961–2970. DOI: 10.1245/s10434–007–9439-z</mixed-citation><mixed-citation xml:lang="en">Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, et al. Clinicopathologic features and long-term outcom es of 2 93phyllodes tum ors of the breast. Ann Surg Oncol 2007; 14 (10): 2961–2970. DOI: 10.1245/s10434–007–9439-z</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Calhoun K, Lawton TJ, Kim JM, et al. Phyllodes tumors. In: Diseases of the breast. Harris J, Lippman ME, Osborne CK, Morrow M (eds). Lippincott Williams and Wilkins, 2010, p.781.</mixed-citation><mixed-citation xml:lang="en">Calhoun K, Lawton TJ, Kim JM, et al. Phyllodes tumors. In: Diseases of the breast. Harris J, Lippman ME, Osborne CK, Morrow M (eds). Lippincott Williams and Wilkins, 2010, p.781.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Telli ML, Horst KC, Guardino AE, Dirbas FM, Carlson RW. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw. 2007 Mar; 5 (3): 324–330. DOI: 10.6004/jnccn.2007.0027</mixed-citation><mixed-citation xml:lang="en">Telli ML, Horst KC, Guardino AE, Dirbas FM, Carlson RW. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw. 2007 Mar; 5 (3): 324–330. DOI: 10.6004/jnccn.2007.0027</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Carter BA, Page DL. Phyllodes tumor of the breast: local recurrence versus metastatic capacity. Hum Pathol. 2004; 35 (9): 1051–1052. DOI: 10.1016/j.humpath.2004.08.001</mixed-citation><mixed-citation xml:lang="en">Carter BA, Page DL. Phyllodes tumor of the breast: local recurrence versus metastatic capacity. Hum Pathol. 2004; 35 (9): 1051–1052. DOI: 10.1016/j.humpath.2004.08.001</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996; 77 (5): 910–916. DOI: 10.1002/(SICI)1097–0142 (19960301)77:5&lt;910:: AID-CNCR16&gt;3.0.CO;2–6</mixed-citation><mixed-citation xml:lang="en">Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996; 77 (5): 910–916. DOI: 10.1002/(SICI)1097–0142(19960301)77:5&lt;910:: AID-CNCR16&gt;3.0.CO;2–6</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. Availavle at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp (Accessed on February 27, 2016)</mixed-citation><mixed-citation xml:lang="en">.National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. Availavle at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp (Accessed on February 27, 2016)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol. 2006; 59 (5): 454–459. DOI: 10.1136/jcp.2005.025866</mixed-citation><mixed-citation xml:lang="en">Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol. 2006; 59 (5): 454–459. DOI: 10.1136/jcp.2005.025866</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jang JH, Choi MY, Lee SK, Kim S, Kim J, Lee J, et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol. 2012 Aug; 19 (8): 2612–7. DOI: 10.1245/s10434–012–2307–5</mixed-citation><mixed-citation xml:lang="en">Jang JH, Choi MY, Lee SK, Kim S, Kim J, Lee J, et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol. 2012 Aug; 19 (8): 2612–7. DOI: 10.1245/s10434–012–2307–5</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tavassoli FA, Devilee P.Genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003. p. 99.</mixed-citation><mixed-citation xml:lang="en">.Tavassoli FA, Devilee P.Genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003. p. 99.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kuijper A, Buerger H, Simon R, Schaefer KL, Croonen A, Boecker W, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol. 2002; 197 (5): 575–581. DOI: 10.1002/path.1161</mixed-citation><mixed-citation xml:lang="en">Kuijper A, Buerger H, Simon R, Schaefer KL, Croonen A, Boecker W, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol. 2002; 197 (5): 575–581. DOI: 10.1002/path.1161</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wiratkapun C, Piyapan P, Lertsithichai P, Larbcharoensub N. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy. Diagn Interv Radiol. 2014 Jan-Feb; 20 (1): 27–33. DOI: 10.5152/dir.2013.13133</mixed-citation><mixed-citation xml:lang="en">Wiratkapun C, Piyapan P, Lertsithichai P, Larbcharoensub N. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy. Diagn Interv Radiol. 2014 Jan-Feb; 20 (1): 27–33. DOI: 10.5152/dir.2013.13133</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Летягин В. П., Ермилова В. Д., Воротников И. К. Злокачественные неэпиелиальные опухоли молочных желез. Вестник РОНЦ им. Н. Н. Блохина РАМН. 1996; 7 (3): 57–59</mixed-citation><mixed-citation xml:lang="en">Letygin VP, Ermilova VD, Vorotnikov IК. Malignant non-epithelial breast tumors. Journal of N. N. Blokhin RCRC. 1996; 7 (3): 57–59.(In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Волченко А. А., Пак Д. Д., Усов Ф. Н., Фетисова Е. Ю. Гигантская листовидная опухоль молочной железы: клиническое наблюдение. Опухоли женской репродуктивной системы. 2012; 2: 27–29.</mixed-citation><mixed-citation xml:lang="en">Volchenko AA, Pak DD, Usov FN, Fetisova EYu. Giant phyllodes tumor of the breast: a clinical observation. Women Reproductive System Tumors. 2012; 2: 27–29.(In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol. 2013 Nov; 88 (2): 427–36. DOI: 10.1016/j.critrevonc.2013.06.005</mixed-citation><mixed-citation xml:lang="en">Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol. 2013 Nov; 88 (2): 427–36. DOI: 10.1016/j.critrevonc.2013.06.005</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000; 89 (7): 1502–1511.</mixed-citation><mixed-citation xml:lang="en">.Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000; 89 (7): 1502–1511.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ward RM, Evans HL. Cystosarcoma phyllodes: a clinicopathologic study of 26 cases. Cancer. 1986; 58 (10): 2282–2289. DOI: 10.1002/1097–0142 (19861115)58:10&lt;2282:: AID-CNCR2820581021&gt;3.0.CO;2–2</mixed-citation><mixed-citation xml:lang="en">.Ward RM, Evans HL. Cystosarcoma phyllodes: a clinicopathologic study of 26 cases. Cancer. 1986; 58 (10): 2282–2289. DOI: 10.1002/1097–0142(19861115)58:10&lt;2282:: AID-CNCR2820581021&gt;3.0.CO;2–2</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfverswärd C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer. 1991; 68 (9): 2017–2022. DOI: 10.1002/1097–0142 (19911101)68:9&lt;2017:: AID-CNCR2820680929&gt;3.0.CO;2-V</mixed-citation><mixed-citation xml:lang="en">Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfverswärd C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer. 1991; 68 (9): 2017–2022. DOI: 10.1002/1097–0142(19911101)68:9&lt;2017:: AID-CNCR2820680929&gt;3.0.CO;2-V</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967; 20 (12): 2090–2099. DOI: 10.1002/1097–0142 (196712)20:12&lt;2090:: AID-CNCR2820201206&gt;3.0.CO;2-L</mixed-citation><mixed-citation xml:lang="en">Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967; 20 (12): 2090–2099. DOI: 10.1002/1097–0142(196712)20:12&lt;2090:: AID-CNCR2820201206&gt;3.0.CO;2-L</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hawkins RE, Schofield JB, Fisher C, Fisher C, Wiltshaw E, McKinna JA. The clinical and histologic criteria that predict m etastases from cystosarcom a phyllodes. Cancer 1992; 69 (1): 141–147. DOI: 10.1002/1097–0142 (19920101)69:1&lt;141:: AID-CNCR2820690125&gt;3.0.CO;2–1</mixed-citation><mixed-citation xml:lang="en">Hawkins RE, Schofield JB, Fisher C, Fisher C, Wiltshaw E, McKinna JA. The clinical and histologic criteria that predict m etastases from cystosarcom a phyllodes. Cancer 1992; 69 (1): 141–147. DOI: 10.1002/1097–0142(19920101)69:1&lt;141:: AID-CNCR2820690125&gt;3.0.CO;2–1</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Fajdić J, Gotovac N, Hrgović Z, Kristek J, Horvat V, Kaufmann M. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas. Onkologie. 2007 Mar; 30 (3): 113–118. DOI: 10.1159/000099580</mixed-citation><mixed-citation xml:lang="en">Fajdić J, Gotovac N, Hrgović Z, Kristek J, Horvat V, Kaufmann M. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas. Onkologie. 2007 Mar; 30 (3): 113–118. DOI: 10.1159/000099580</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 2006; 107 (9): 2127–2133. DOI: 10.1002/cncr.22228</mixed-citation><mixed-citation xml:lang="en">Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 2006; 107 (9): 2127–2133. DOI: 10.1002/cncr.22228</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol. 2009 Aug; 16 (8): 2288–2294. DOI: 10.1245/s10434–009–0489–2</mixed-citation><mixed-citation xml:lang="en">Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol. 2009 Aug; 16 (8): 2288–2294. DOI: 10.1245/s10434–009–0489–2</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant m etastases following prim ary surgical treatm ent of highgrade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001; 27 (8): 723–730. DOI: 10.1053/ejso.2001.1207</mixed-citation><mixed-citation xml:lang="en">Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant m etastases following prim ary surgical treatm ent of highgrade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001; 27 (8): 723–730. DOI: 10.1053/ejso.2001.1207</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J. 2001 Jul; 77 (909): 428–435. DOI: 10.1136/pmj.77.909.428</mixed-citation><mixed-citation xml:lang="en">Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J. 2001 Jul; 77 (909): 428–435. DOI: 10.1136/pmj.77.909.428</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 2008; 70 (2): 492–500. DOI: 10.1016/j.ijrobp.2007.06.059</mixed-citation><mixed-citation xml:lang="en">.Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 2008; 70 (2): 492–500. DOI: 10.1016/j.ijrobp.2007.06.059</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Pezner RD, Schultheiss TE, Paz IB. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008 Jul 1; 71 (3): 710–713. DOI: 10.1016/j.ijrobp.2007.10.051</mixed-citation><mixed-citation xml:lang="en">.Pezner RD, Schultheiss TE, Paz IB. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008 Jul 1; 71 (3): 710–713. DOI: 10.1016/j.ijrobp.2007.10.051</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol. 2014 Apr; 21 (4): 1222–30. DOI: 10.1245/s10434–013–3395–6</mixed-citation><mixed-citation xml:lang="en">Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009.Ann Surg Oncol. 2014 Apr; 21 (4): 1222–30. DOI: 10.1245/s10434–013–3395–6</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Morales-Vásquez F, Gonzalez-Angulo AM, Broglio K, Lopez-Basave HN, Gallardo D, Hortobagyi GN, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free surviv al of m alignant phyllodes tumors of the breast. Breast J. 2007 Nov-Dec; 13 (6): 551–556. DOI: 10.1111/j.1524–4741.2007.00510.x</mixed-citation><mixed-citation xml:lang="en">Morales-Vásquez F, Gonzalez-Angulo AM, Broglio K, Lopez-Basave HN, Gallardo D, Hortobagyi GN, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free surv iv al of m alignant phyllodes tum ors of the breast. Breast J. 2007 Nov-Dec; 13 (6): 551–556. DOI: 10.1111/j.1524–4741.2007.00510.x</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Burton GV, Hart LL, Leight GS Jr, Iglehart JD, McCarty KS Jr, Cox EB. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer. 1989; 63 (11): 2088–2092. DOI: 10.1002/1097–0142 (19890601)63:11&lt;2088:: AID-CNCR2820631103&gt;3.0.CO;2-C</mixed-citation><mixed-citation xml:lang="en">Burton GV, Hart LL, Leight GS Jr, Iglehart JD, McCarty KS Jr, Cox EB. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer. 1989; 63 (11): 2088–2092. DOI: 10.1002/1097–0142(19890601)63:11&lt;2088:: AID-CNCR2820631103&gt;3.0.CO;2-C</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, et al. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol 2006; 19 (4): 599–606. DOI: 10.1038/modpathol.3800574</mixed-citation><mixed-citation xml:lang="en">Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, et al. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol 2006; 19 (4): 599–606. DOI: 10.1038/modpathol.3800574</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Tse GM, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, et al. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Am J Clin Pathol. 2002; 118 (4): 522–526. DOI: 10.1309/D206-DLF8-WDNC–XJ8K</mixed-citation><mixed-citation xml:lang="en">Tse GM, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, et al. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Am J Clin Pathol. 2002; 118 (4): 522–526. DOI: 10.1309/D206-DLF8-WDNC–XJ8K</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Confavreux C, Lurkin A, Mitton N, Blondet R, Saba C, Ranchère D, et al. Sarcomas and malignant phyllodes tumours of the breast — a retrospective study. Eur J Cancer. 2006 Nov; 42 (16): 2715–2721. DOI: 10.1016/j.ejca.2006.05.040</mixed-citation><mixed-citation xml:lang="en">Confavreux C, Lurkin A, Mitton N, Blondet R, Saba C, Ranchère D, et al. Sarcomas and malignant phyllodes tumours of the breast — a retrospective study. Eur J Cancer. 2006 Nov; 42 (16): 2715–2721. DOI: 10.1016/j.ejca.2006.05.040</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
